| abstract |
Methods for treating a pulmonary sarcoidosis patient are provided. The compositions are formulated for delivery to a patient in need of treatment via inhalation. In one embodiment, the method of treating pulmonary sarcoidosis in a patient in need thereof includes administering to the lungs of the patient via inhalation, a composition comprising an effective amount of a treprostinil prodrug, for example, a treprostinil alkyl ester prodrug (e.g., linear C13-C18 alkyl, branched C13-C18 alkyl) or a composition comprising the same. The composition in one embodiment, includes a PEGylated lipid and squalane. |